EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 29 / No 11 (Novembre 2013) Med Sci (Paris), 29 11 (2013) 940-942 References
Free Access
Issue
Med Sci (Paris)
Volume 29, Number 11, Novembre 2013
Page(s) 940 - 942
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20132911003
Published online 20 November 2013
  1. Passegué E, Wagers AJ, Giuriato S, et al. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med 2005 ; 202 : 1599–1611. [CrossRef] [PubMed] [Google Scholar]
  2. Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 2006 ; 6 : 93–106. [CrossRef] [PubMed] [Google Scholar]
  3. Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002 ; 30 : 973–981. [CrossRef] [PubMed] [Google Scholar]
  4. Fortunel NO, Hatzfeld A, Hatzfeld JA. Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood 2000 ; 96 : 2022–2036. [PubMed] [Google Scholar]
  5. Scandura JM, Boccuni P, Massagué J, Nimer SD. Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc Natl Acad Sci USA 2004 ; 101 : 15231–15236. [CrossRef] [Google Scholar]
  6. Levéen P, Larsson J, Ehinger M, et al. Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood 2002 ; 100 : 560–568. [CrossRef] [PubMed] [Google Scholar]
  7. Yaswen L, Kulkarni AB, Fredrickson T, et al. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood 1996 ; 87 : 1439–1445. [PubMed] [Google Scholar]
  8. Matsumoto A, Takeishi S, Kanie T, et al. p57 is required for quiescence and maintenance of adult hematopoietic stem cells. Cell Stem Cell 2011 ; 9 : 262–271. [CrossRef] [PubMed] [Google Scholar]
  9. Brenet F, Kermani P, Spektor R, et al. TGF-beta restores hematopoietic homeostasis after myelosuppressive chemotherapy. J Exp Med 2013 ; 210 : 623–639. [CrossRef] [PubMed] [Google Scholar]
  10. Yan Y, Frisén J, Lee MH, et al. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev 1997 ; 11 : 973–983. [CrossRef] [PubMed] [Google Scholar]
  11. Lyman GHJ. Impact of chemotherapy dose intensity on cancer patient outcomes. Natl Compr Canc Netw 2009 ; 7 : 99–108. [Google Scholar]
  12. Yingling JM, Blanchard KL, Sawyer JS. Development of TGF-beta signalling inhibitors for cancer therapy. Nat Rev Drug Discov 2004 ; 3 : 1011–1022. [CrossRef] [PubMed] [Google Scholar]
  13. Muraoka RS, Dumont N, Ritter CA, et al. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J Clin Invest 2002 ; 109 : 1551–1559. [PubMed] [Google Scholar]
  14. Lataillade JJ, Brunet de la Grange P, Uzan G, Le Bousse-Kerdilès MC. Les cellules souches ont-elles l’âge de leur niche ? Med Sci (Paris) 2010 ; 26 : 582–585. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.